Rebuilding Trust: The Healthcare Marketer’s Perspective
Much has been written about the erosion of public trust in the pharmaceutical industry. Today, major pharmaceutical companies and their biggest industry group, Pharmaceutical Research and Manufacturers of America (PhRMA), are making rebuilding trust a centerpiece of the underlying mission in their conversation with society. With Election Day drawing near, industry observers are beginning to speculate on how the pharmaceutical industry will fare under a new president. It seems that on the issue of getting tough with the industry, the two candidates agree.
So, with a likely scenario of continued price pressures, patent expiration, the proliferation of generics and declining marketing budgets, what is the healthcare marketer’s path to success? How should healthcare communications be shaped to compete effectively in what some may call a hostile environment, without losing sight of that loftier goal of rebuilding trust with the public?
This week’s poll looks at some of the recurring themes in the media and in conversations among marketers. Give us your perspective by casting your vote, posting a comment, or sending me an e-mail. I’ll give you a summary report in a couple of weeks.